Methodological weakness in using correlation coefficients for assessing the interchangeability of analyte data between samples collected under different sampling conditions - the example of matrix metalloproteinase 9 determined in serum and plasma samples

被引：6
作者：
Jung, Klaus [1 ,2 ]
Wu, Chun-Ying [3 ,4 ,5 ]
机构：
[1] Charite, Dept Urol, D-10117 Berlin, Germany
[2] Berlin Inst Urol Res, Berlin, Germany
[3] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan
[4] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan
[5] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2010年 / 48卷 / 05期
关键词：
comparative measurements; correlation coefficient; interfering factors; matrix metalloproteinases; sampling condition; MATRIX-METALLOPROTEINASE (MMP)-2; BLOOD;
D O I：
10.1515/CCLM.2010.135
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：733 / 736
页数：4
相关论文
共 10 条
  • [1] MEASUREMENT IN MEDICINE - THE ANALYSIS OF METHOD COMPARISON STUDIES
    ALTMAN, DG
    BLAND, JM
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES D-THE STATISTICIAN, 1983, 32 (03) : 307 - 317
  • [2] [Anonymous], 2006, TIETZ TXB CLIN CHEM
  • [3] Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
  • [4] Positive correlations between serum and plasma matrix metalloproteinase (MMP)-2 or MMP-9 levels in disease conditions
    Gerlach, Raquel F.
    Meschiari, Cesar A.
    Marcaccini, Andrea M.
    Palei, Ana C. T.
    Sandrim, Valeria C.
    Cavalli, Ricardo C.
    Tanus-Santos, Jose E.
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2009, 47 (07) : 888 - 891
  • [5] Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
    Gerlach, RF
    Uzuelli, JA
    Souza-Tarla, CD
    Tanus-Santos, JE
    [J]. ANALYTICAL BIOCHEMISTRY, 2005, 344 (01) : 147 - 149
  • [6] Johnson Roger, 2008, Clin Biochem Rev, V29 Suppl 1, pS37
  • [7] Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood
    Jung, K
    Lein, M
    Laube, C
    Lichtinghagen, R
    [J]. CLINICA CHIMICA ACTA, 2001, 314 (1-2) : 241 - 244
  • [8] Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma
    Makowski, GS
    Ramsby, ML
    [J]. ANALYTICAL BIOCHEMISTRY, 2003, 322 (02) : 283 - 286
  • [9] Serum or plasma samples? The "Cinderella" role of blood collection procedures - Preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation
    Mannello, Ferdinando
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (04) : 611 - 614
  • [10] Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution
    Wu, Chun-Ying
    Wu, Ming-Shiang
    Chiang, En-Pei
    Chen, Yi-Ju
    Chen, Chien-Jen
    Chi, Nai-Hui
    Shih, Ying-Ting
    Chen, Gran-Hum
    Lin, Jaw-Town
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2054 - 2060
1